Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anew Medical Inc. (KLTOW:NASDAQ), powered by AI.
Anew Medical Inc. is currently trading at $0.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Anew Medical Inc. on Alpha Lenz.
View Anew Medical Inc.'s valuation metrics on Alpha Lenz.
“Anew Medical Inc.'s ROE is -700.1%. Explore profitability and growth together.”
Ask for details →Anew Medical Inc. is a biotechnology company dedicated to the development and commercialization of innovative medical solutions. Its primary function is to enhance healthcare through cutting-edge biotechnological research aimed at discovering new therapies and treatments. Anew Medical Inc. is particularly focused on creating groundbreaking therapies in the fields of oncology, neurology, and rare diseases, striving to address unmet medical needs in these critical areas. The company's approach often involves leveraging genetic research and advanced biological sciences to create targeted treatment options. In the financial markets, Anew Medical Inc. holds a significant position due to its potential to revolutionize treatment landscapes and improve patient outcomes globally. Through partnerships with leading research institutions and a robust pipeline of clinical trials, the company plays a crucial role in the rapidly growing biotechnology sector, attracting attention from investors, medical professionals, and regulatory bodies alike.
“Anew Medical Inc.'s ROE is -700.1%. Explore profitability and growth together.”
Ask for details →Anew Medical Inc. (ticker: KLTOW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 3 employees.
The current price is $0.099 with a P/E ratio of -x and P/B of -x.
ROE is -700.07%.